Clinical Trial Update: A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]

View source ↗

Summary

A phase 3 randomized trial comparing a long-acting injectable risperidone formulation to olanzapine tablets in adults with schizophrenia or schizoaffective diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)
• Zyprexa (olanzapine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED